Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy: Page 213
Elekta gets FDA nod for Agility
By
AuntMinnie.com staff writers
Radiation oncology firm Elekta has received 510(k) clearance from the U.S. Food and Drug Administration for Agility, a beam-shaping device integrated into the head of a linear accelerator.
June 13, 2012
ACS reports 13.7M cancer survivors in U.S.
By
Cynthia E. Keen
The American Cancer Society (ACS), working in collaboration with the U.S. National Cancer Institute, has published its first report surveying cancer survivorship in the U.S., estimating that 13.7 million cancer patients have survived their disease.
June 13, 2012
IsoRay promotes cesium-131 for meningioma
By
AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical has reported that a cesium-131 brachytherapy sutured mesh implant in a patient with a recurring meningioma tumor has kept the patient tumor-free for 90 days.
June 12, 2012
Accuray installs 1st TomoHD system in Fla.
By
AuntMinnie.com staff writers
Radiation oncology firm Accuray has installed its first TomoHD system at MD Anderson Cancer Center Orlando, which is part of Orlando Health, a 1,882-bed, community-owned, not-for-profit organization.
June 11, 2012
ISRRT: Fear of retaliation may impede radiation error reporting
By
Louise Gagnon
TORONTO - While healthcare institutions in the U.S. may point to institutional policies that encourage staff to report errors, radiation therapists and medical dosimetrists surveyed at these institutions say they are concerned about possible retaliation when reporting errors.
June 11, 2012
SNM: Patch has potential as skin cancer treatment
By
AuntMinnie.com staff writers
A customized patch treatment for basal cell carcinoma completely destroyed facial tumors without surgery or major radiation therapy in 80% of patients studied, according to results presented at the Society of Nuclear Medicine annual meeting under way in Miami Beach, FL.
June 11, 2012
Mevion gets FDA nod for proton therapy system
By
AuntMinnie.com staff writers
Proton therapy developer Mevion Medical Systems has received 510(k) clearance for its S250 proton therapy system from the U.S. Food and Drug Administration.
June 11, 2012
SNM: New therapy extends life for prostate cancer patients
By
AuntMinnie.com staff writers
Survival is bleak for prostate cancer patients with advanced tumors that have spread to the bone, but a radioisotope procedure being evaluated in a clinical trial is extending lives by several months, according to a study presented at the Society of Nuclear Medicine (SNM) annual meeting, being held in Miami Beach, FL, this week.
June 10, 2012
SNM Image of the Year goes to Bi-123 DOTATOC radiotracer
By
Wayne Forrest
MIAMI BEACH, FL - German researchers have received this year's Image of the Year award at the Society of Nuclear Medicine (SNM) annual meeting for their research illustrating the effectiveness of a new radiopharmaceutical for treating digestive tumors.
June 10, 2012
ISRRT: Radiation therapy filmcards may harbor bacteria
By
Louise Gagnon
TORONTO - Filmcards used in setting up radiation therapy procedures are a source of cross-infection in hospitals, and organisms such as
Staphylococcus aureus
are present on the filmcards, according to a study presented at the International Society of Radiographers and Radiological Technologists meeting.
June 10, 2012
Nordion revenues fall in Q2
By
AuntMinnie.com staff writers
Timing of cobalt-60 shipments to customers and the planned one-month National Research Universal reactor shutdown contributed to a 27% drop in revenue for Nordion in its second quarter.
June 7, 2012
Accuray touts CyberKnife prostate SBRT study
By
AuntMinnie.com staff writers
Radiation oncology firm Accuray is touting the results of a study that concluded that use of the company's CyberKnife system for prostate stereotactic body radiation therapy (SBRT) can provide positive long-term outcomes for intermediate-risk prostate cancer patients.
June 6, 2012
Previous Page
Page 213 of 464
Next Page